Search This Blog

Wednesday, May 14, 2025

Trump's drug pricing order threatens Roche's $50 billion US investment plans, company says

 U.S. President Donald Trump’s recent executive order on drug pricing could potentially jeopardize Swiss pharmaceutical company Roche’s planned $50 billion investment in the United States. Roche, listed as ROG.S, expressed this concern on Wednesday.

The executive order, signed by President Trump on Monday, instructs pharmaceutical firms to reduce the prices of brand-name drugs to match those in other affluent countries. However, several analysts and legal professionals have voiced that implementing such a policy might pose significant challenges.

https://www.investing.com/news/stock-market-news/trumps-drug-pricing-order-threatens-roches-50b-us-investment-co-says-93CH-4045400

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.